Cervical cancers avoided by HPV immunisation

Maggie Cruickshank* (Corresponding Author), Mihaela Grigore

*Corresponding author for this work

Research output: Contribution to journalComment/debatepeer-review

Abstract

In 2020, WHO launched a global strategy to accelerate the elimination of cervical cancer as a public health problem, 1 one of the most common causes of cancer deaths in women globally. While recognising that the burden of disease is carried by low-income countries, WHO did not avoid setting challenging targets. Where there are no existing cancer control measures, WHO believes the priority should be human papillomavirus (HPV) immunisation of girls to prevent future cervical cancers and other HPV-related malignancies.
Original languageEnglish
Pages (from-to)P2053-2055
Number of pages3
JournalThe Lancet
Volume398
Issue number10361
Early online date3 Nov 2021
DOIs
Publication statusPublished - 4 Dec 2021

Fingerprint

Dive into the research topics of 'Cervical cancers avoided by HPV immunisation'. Together they form a unique fingerprint.

Cite this